These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23890857

  • 1. Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials.
    Takagi H, Umemoto T, All-Literature Investigation of Cardiovascular Evidence (ALICE) Group.
    Int J Cardiol; 2013 Oct 12; 168(5):4850-3. PubMed ID: 23890857
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy.
    Weart CW, Hogan RJ.
    Expert Opin Pharmacother; 2011 Jan 12; 12(1):99-117. PubMed ID: 21108580
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A, Sabbah L, Perdrix L, Blanchard D, Danchin N, Puymirat E.
    Arch Cardiovasc Dis; 2013 Oct 12; 106(10):511-6. PubMed ID: 24080324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z, Zhang Y, Gao M, Wang J, Wang Q, Wang X, Su L, Hou Y.
    Pharmacotherapy; 2011 Nov 12; 31(11):1051-62. PubMed ID: 22026393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
    Zhai C, Hou K, Li R, Hu Y, Zhang J, Zhang Y, Wang L, Zhang R, Cong H.
    J Int Med Res; 2020 Jun 12; 48(6):300060520926349. PubMed ID: 32529863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 15. Treating Dyslipidemia for the Primary and Secondary Prevention of Stroke.
    Barkas F, Milionis H.
    Semin Neurol; 2017 Jun 16; 37(3):286-293. PubMed ID: 28759910
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H, Brugts J, Ades T.
    Circ Cardiovasc Qual Outcomes; 2013 Jul 16; 6(4):390-9. PubMed ID: 23838105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.